Cortavance

RSS

hydrocortisone

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 06/11/2018

Authorisation details

Product details
Name
Cortavance
Agency product number
EMEA/V/C/000110
Active substance
hydrocortisone aceponate
International non-proprietary name (INN) or common name
hydrocortisone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QD07AC
Publication details
Marketing-authorisation holder
Virbac S.A.
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
09/01/2007
Contact address

1ère Avenue 2065 M - L.I.D.
06516 Carros Cedex
France

Product information

26/10/2018 Cortavance - EMEA/V/C/000110 - IG/0984 (0012)

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Corticosteroids
  • Dermatological preparations

Therapeutic indication

For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.

Assessment history

How useful was this page?

Add your rating